Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis

Blood

Volumn 97, Issue 11, 2001, Pages 3581-3588

  Kolomietz, Elena ^a   Al Maghrabi, Jaudah ^a   Brennan, Shawn ^a   Karaskova, Jana ^a   Minkin, Solomon ^a   Lipton, Jeffrey ^a   Squire, Jeremy A ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; MIXED LINEAGE LEUKEMIA PROTEIN;

ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CHROMOSOME 9Q; CHROMOSOME REARRANGEMENT; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DISEASE COURSE; DNA STRAND BREAKAGE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE TRANSLOCATION; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROGNOSIS; SEQUENCE ANALYSIS;

EID: 0035383839     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.11.3581     Document Type: Article

References (63)

1. Aplan PD. Mechanism of leukemogenesis: chromosomal translocations. In: Schechter GP, exec ed. Hematology 1999: American Society of Hematology Education Program Book. Washington, DC: American Society of Hematology; 1999:77-82.
2. Deininger MW, Goldman JM. Chronic myeloid leukemia. Curr Opin Hematol. 1998;5:302-308.
3. Sinclair PB, Nacheva EP, Leversha M, et al. Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia. Blood. 2000;95:738-743.
4. Buno I, Wyatt WA, Zinsmeister AR, et al. A special fluorescent in situ hybridization technique to study peripheral blood and assess the effectiveness of interferon therapy in chronic myeloid leukemia. Blood. 1998;92:2315-2321.
5. Marlton P, Claxton DF, Liu P, et al. Molecular characterization of 16p deletions associated with inversion 16 defines the critical fusion for leukemogenesis. Blood, 1995;85:772-779,
6. Martinet D, Muhlematter D, Leeman M, et al. Detection of 16 p deletions by FISH in patients with inv(16) or t(16;16) and acute myeloid leukemia (AML). Leukemia. 1997;11:964-970.
7. Smit AF. Interspersed repeats and other mementos of transposable elements in mammalian genomes. Curr Opin Genet Dev. 1999;9:657-663.
8. Jin DY, Spencer F, Jeang KT, Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell. 1998; 93:81-91.
9. Burger PC, Yu IT, Tihan T, et al. Atypical teratoid/ rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a Pediatric Oncology Group study. Am J Surg Pathol. 1998;22:1083-1092.
10. Biegel JA, Rorke LB, Packer RJ, Emanuel BS. Monosomy 22 in rhabdoid or atypical tumors of the brain. J Neurosurg. 1990;73:710-714.
11. Sevenet N, Lellouch-Tubiana A, Schofield D, et al. Spectrum of hSNF5/INI1 somatic mutatfons in human cancer and genotype-phenotype correlations. Hum Mol Genet. 1999;8:2359-2368.
12. Muchardt C, Sardet C, Bourachot B, Onufryk C, Yaniv M. A human protein with homology to Saccharomyces cerevisiae SNF5 interacts with the potential helicase hbrm. Nucleic Acids Res. 1995; 23:1127-1132.
13. Wang W, Xue Y, Zhou S, et al. Diversity and specialization of mammalian SWI/SNF complexes. Genes Dev. 1996;10:2117-2130.
14. Versteege I, Sevenet N, Lange J, et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature. 1998;394:203-206.
15. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p53-induced apoptosis. Nature. 1997;389:300-305.
16. Di Bacco A, Keeshan K, McKenna SL, Cotter TG. Molecular abnormalities in chronic myeloid leukemia: deregulation of cell growth and apoptosis [In Process Citation]. Oncologist. 2000;5:405-415.
17. Gisslinger H, Kurzrock R, Wetzler M, et al. Apoptosis in chronic myelogenous leukemia: studies of stage-specific differences. Leuk Lymphoma. 1997;25:121-133.
18. Cambier N, Chopra R, Strasser A, Metcalf D, Elefanty AG. BCR-ABL activates pathways mediating cytokine independence and protection against apoptosis in murine hematopoietic cells in a dose-dependent manner. Oncogene. 1998;16: 335-348.
19. Aspenstrom P. A Cdc42 target protein with homology to the non-kinase domain of FER has a potential role in regulating the actin cytoskeleton. Curr Biol. 1997;7:479-487.
20. Bhatia R, Munthe HA, Verfaillie CM. Role of abnormal integrin-cytoskeletal interactions in impaired beta 1 integrin function in chronic myelogenous leukemia hematopoietic progenitors. Exp Hematol. 1999;27:1384-1396.
21. Weisberg E, Sattler M, Ewaniuk DS, Salgia R. Role of focal adhesion proteins in signal transduction and oncogenesis. Crit Rev Oncog. 1997; 8:343-358.
22. Salgia R, Li JL, Ewaniuk DS, et al. BCR/ABL induces multiple abnormalities of cytoskeletal function. J Clin Invest. 1997;100:46-57.
23. Grand F, Kulkarni S, Chase A, et al. Frequent deletion of hSNF5/INI1, a component of the SWI/ SNF complex, in chronic myeloid leukemia. Cancer Res. 1999;59:3870-3874.
24. van Der Kolk DM, Vellenga E, van Der Veen AY, et al. Deletion of the multidrug resistance protein MRP1 gene in acute myeloid leukemia: the impact on MRP activity [In Process Citation]. Blood. 2000;95:3514-3519.
25. Corral J, Forster A, Thompson S, et al. Acute leukemias of different lineages have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocation. Proc Natl Acad Sci U S A. 1993;90:8538-8542.
26. Rowley JD. 1993 Robert R, deVilliers Lecture. Chromosome translocations: dangerous liaisons. Leukemia. 1994;8(suppl 1):S1-S6.
27. Markovic VD, Bouman D, Bayani J, et al. Lack of BCR/ABL reciprocal fusion in variant Philadelphia chromosome translocations: a use of double fusion signal FISH and spectral karyotyping [letter]. Leukemia. 2000;14:1157-1160.
28. Heim S, Mitelman F. Cancer Cytogenetics. 2nd ed. New York, NY: Wiley-Liss; 1995.
29. Tycko B, Sklar J. Chromosomal translocations in lymphoid neoplasia: a reappraisal of the recombinase model. Cancer Cells. 1990;2:1-8.
30. Jeffs AR, Benjes SM, Smith TL, Sowerby SJ, Morris CM. The BCR gene recombines preferentially with Alu elements in complex BCR-ABL translocations of chronic myeloid leukaemia. Hum Mol Genet. 1998;7:767-776.
31. Huie ML, Shanske AL, Kasper JS, Marion RW, Hirschhorn R. A large Alu-mediated deletion, identified by PCR, as the molecular basis for glycogen storage disease type II (GSDII). Hum Genet. 1999;104:94-98.
32. Kasai M, Matsuzaki T, Katayanagi K, et al. The translin ring specifically recognizes DNA ends at recombination hot spots in the human genome. J Biol Chem. 1997;272:11402-11407.
33. Aoki K, Suzuki K, Sugano T, et al. A novel gene, Translin, encodes a recombination hotspot binding protein associated with chromosomal translocations. Nat Genet. 1995;10:167-174.
34. Boehm T, Mengle-Gaw L, Kees UR, et al. Alternating purine-pyrimidine tracts may promote chromosomal translocations seen in a variety of human lymphoid tumours. EMBO J. 1989;8:2621-2631.
35. Felix CA. Secondary leukemias induced by topoisomerase-targeted drugs. Biochim Biophys Acta. 1998;1400:233-255.
36. Glover TW, Stein CK. Chromosome breakage and recombination at fragile sites. Am J Hum Genet. 1988;43:265-273.
37. Wenger SL. Relationship between fragile sites and cancer breakpoints [letter]. Cancer Genet Cytogenet. 1992;61:213.
38. Chissoe SL, Bodenteich A, Wang YF, et al. Sequence and analysis of the human ABL gene, the BCR gene, and regions involved in the Philadelphia chromosomal translocation, Genomics. 1995;27:67-82.
39. Zhang JG, Goldman JM, Cross NC. Characterization of genomic BCR-ABL breakpoints in chronic myeloid leukaemia by PCR. Br J Haematol. 1995;90:138-146.
40. Sowerby SJ, Kennedy MA, Fitzgerald PH, Morris CM. DNA sequence analysis of the major breakpoint cluster region of the BCR gene rearranged in Philadelphia-positive human leukemias. Oncogene. 1993;8:1679-1683.
41. Papadopoulos PC, Greenstein AM, Gaffney RA, Westbrook CA, Wiedemann LM. Characterization of the translocation breakpoint sequences in Philadelphia-positive acute lymphoblastic leukemia. Genes Chromosomes Cancer. 1990;1:233-239.
42. Chen SJ, Chen Z, Font MP, et al. Structural alterations of the BCR and ABL genes in Ph1 positive acute leukemias with rearrangements in the BCR gene first intron: further evidence implicating Alu sequences in the chromosome translocation. Nucleic Acids Res. 1989;17:7631-7642.
43. Tvrdik T, Marcus S, Hou SM, et al. Molecular characterization of two deletion events involving Alu-sequences, one novel base substitution and two tentative hotspot mutations in the hypoxanthine phosphoribosyltransferase (HPRT) gene in five patients with Lesch-Nyhan syndrome. Hum Genet. 1998;103:311-318.
44. Szostak JW, Orr-Weaver TL, Rothstein RJ, Stahl FW. The double-strand-break repair model for recombination. Cell. 1983;33:25-35.
45. Hornigold N, Devlin J, Davies AM, et al. Mutation of the 9q34 gene TSC1 in sporadic bladder cancer. Oncogene. 1999;18:2657-2661.
46. Green AJ, Johnson PH, Yates JR. The tuberous sclerosis gene on chromosome 9q34 acts as a growth suppressor. Hum Mol Genet. 1994;3: 1833-1834.
47. Zhou J, Fogelgren B, Wang Z, Roe BA, Biegel JA. Isolation of genes from the rhabdoid tumor deletion region in chromosome band 22q11.2. Gene. 2000;241:133-141.
48. Mori T, Fukuda Y, Kuroda H, et al. Cloning and characterization of a novel Rab-family gene, Rab36, within the region at 22q11.2 that is homozygously deleted in malignant rhabdoid tumors. Biochem Biophys Res Commun. 1999; 254:594-600.
49. Filippova GN, Lindblom A, Meincke LJ. et al. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers. Genes Chromosomes Cancer. 1998;22:26-36.
50. Harbott J, Mancini M. Verellen-Dumoulin C, Moorman AV, Secker-Walker LM. Hematological malignancies with a deletion of 11q23: cytogenetic and clinical aspects. European 11q23 Workshop participants. Leukemia. 1998;12:823-827.
51. Lens D, Matutes E, Catovsky D, Coignet LJ. Frequent deletions at 11q23 and 13q14 in B cell prolymphocytic leukemia (B-PLL). Leukemia. 2000;14:427-430.
52. Skomedal H, Helland A, Kristensen GB, Holm R, Borresen-Dale AL. Allelic imbalance at chromosome region 11q23 in cervical carcinomas. Eur J Cancer. 1999;35:659-663.
53. Guo C, White PS, Weiss MJ, et al. Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas. Oncogene. 1999;18:4948-4957.
54. Hoffman R. Hematology: Basic Principles and Practice. 3rd ed. New York, NY: Churchill-Livingstone; 2000:1157.
55. Hoffbrand AV, Tuddenham EGD, Lewis SM. Postgraduate Haematology. 4th ed. Boston, MA: Heinemann Professional Pub; 1999:435.
56. Entrez database. [database online]. Bethesda, MD: National Center for Biotechnology Information. Updated February 12, 2001.
57. The Genome Database. [database online]. Toronto, ON, Canada: The Hospital for Sick Children. Updated February 23, 2001.
58. Database Search Services at the Sanger Center. [database online]. Cambridge, United Kingdom. Updated February 26, 2001.
59. Electronic PCR. National Center for Biotechnology Information Web site. Available at: http:/www. ncbi.nlm.nih.gov/genome/sts/epcr.cgi. Accessed March 2000.
60. Genome Channel and Genome Catalog. Computational Biology Section of the Life Sciences Division of Oak Ridge National Laboratory Web site. Available at: http://compbio.orni.gov. Accessed March 2000.
61. Censor Server Data Entry Form. [database online]. Sunnyvale, CA: Genetic Information Research Institute. Updated February 28, 2001.
62. The Repeat Masker Server. [database online]. Washington, DC: University of Washington. Updated July 16, 2000.
63. Mitelman Database of Chromosome Aberrations in Cancer. [online database]. Bethesda, MD: The Cancer Genome Anatomy project of National Cancer Institute. Updated January 23, 2001.